Evidence map›Paper›PMID 23900513›Full record

ArticleNature communications2013

The RAG2 C-terminus and ATM protect genome integrity by controlling antigen receptor gene cleavage.

Julie Chaumeil, Mariann Micsinai, Panagiotis Ntziachristos, David B Roth, Iannis Aifantis, Yuval Kluger, Ludovic Deriano, Jane A Skok

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The ATM Kinase Restrains Joining of Both VDJ Signal and Coding Ends.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Long-Range Regulation of V(D)J Recombination.Advances in immunology · 2015
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Julie ChaumeilDepartment of Pathology, New York University School of Medicine, New York, New York 10016, USA.
Mariann Micsinai
Panagiotis Ntziachristos
David B Roth
Iannis Aifantis
Yuval Kluger
Ludovic Deriano
Jane A Skok
New York University · USCancer Research Institute · USHoward Hughes Medical Institute · USInstitut Pasteur · FRYale Cancer Center · USYale University · US

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Role of TET2 mutations in malignant transformation and acute myeloid leukemiaR01CA173636 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AIFANTIS, IANNIS, LEVINE, ROSS L · 2013 to 2022
$6.3M
Role Of Nuclear Organization In Protecting Genome Stability During RecombinationR01GM086852 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLUGER, YUVAL, SKOK, JANE AMANDA · 2008 to 2016
$3.8M
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.R01CA133379 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2009 to 2018
$3.6M
Regulation of hematopoietic stem cell differentiationR01CA105129 · NCI · UNIVERSITY OF CHICAGO · PI AIFANTIS, IANNIS · 2005 to 2014
$2.8M
RAG-induced DNA damage: mechanisms and responsesR01CA104588 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROTH, DAVID B. · 2004 to 2014
$2.8M
Mechanisms of T cell leukemia induction and maintenanceR01CA149655 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2010 to 2015
$2.0M
Regulation of cyclin D3 in B lymphocyte developmentR01GM088847 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2010 to 2013
$1.2M
Role of ATM and RAG in maintaining genome stability during Tcra/d rearrangement.R56AI099111 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLUGER, YUVAL, SKOK, JANE AMANDA · 2012 to 2013
$815k
Howard Hughes Medical InstituteNCI NIH HHS CA104588NCI NIH HHS CA-16359NCI NIH HHS P30 CA016087NCI NIH HHS P30 CA016359NCI NIH HHS R01 CA104588NCI NIH HHS R01 CA105129NCI NIH HHS R01CA105129NCI NIH HHS R01 CA133379NCI NIH HHS R01CA133379NCI NIH HHS R01 CA149655NCI NIH HHS R01CA149655NCI NIH HHS R01 CA173636NCI NIH HHS R01CA173636NIAID NIH HHS R56 AI099111NIGMS NIH HHS R01 GM086852NIGMS NIH HHS R01GM086852NIGMS NIH HHS R01 GM088847NIGMS NIH HHS R01GM088847PHS HHS R56NIAIDAI099111
6 · The paper itself

Abstract

Tight control of antigen-receptor gene rearrangement is required to preserve genome integrity and prevent the occurrence of leukaemia and lymphoma. Nonetheless, mistakes can happen, leading to the generation of aberrant rearrangements, such as Tcra/d-Igh inter-locus translocations that are a hallmark of ataxia telangiectasia-mutated (ATM) deficiency. Current evidence indicates that these translocations arise from the persistence of unrepaired breaks converging at different stages of thymocyte differentiation. Here we show that a defect in feedback control of RAG2 activity gives rise to bi-locus breaks and damage on Tcra/d and Igh in the same T cell at the same developmental stage, which provides a direct mechanism for generating these inter-locus rearrangements. Both the RAG2 C-terminus and ATM prevent bi-locus RAG-mediated cleavage through modulation of three-dimensional conformation (higher-order loops) and nuclear organization of the two loci. This limits the number of potential substrates for translocation and provides an important mechanism for protecting genome stability.

Indexed as

Gene Rearrangement, alpha-Chain T-Cell Antigen ReceptorGene Rearrangement, delta-Chain T-Cell Antigen ReceptorGenomic InstabilityAnimalsAtaxia Telangiectasia Mutated ProteinsDNA-Binding ProteinsGenetic LociMiceReceptors, Antigen, T-Cell, alpha-betaAtaxia Telangiectasia Mutated ProteinsDNA-Binding ProteinsRag2 protein, mouseReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID23900513
PMCPMC3903180
OpenAlexW2004042867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.